All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.
Categories
Recent Posts
CJC-1295 Peptide Research: GHRH Analog and Growth Hormone
Explore CJC-1295, a GHRH analog originally developed as an investigational compound. Studies have measured its effects on growth hormone and IGF-1 levels.
PP-TS1: GHRH Analog Research
PP-TS1 is a growth hormone-releasing hormone analog studied for its stability, GHRH-receptor pharmacology and GH/IGF-1 responses. A summary of the published literature.
Peptides and Aging Biology: A Research Overview
Peptides are gaining attention as research tools in aging biology. These short chains of amino acids regulate cellular repair, inflammation, and hormonal balance, processes that are studied in research on age-related conditions. Recent research has examined their interactions with aging mechanisms. This article explores peptides’ role in aging biology research and the challenges facing this field.
Peptide MOTS-c Research: Mitochondrial Metabolic Studies
Brief Overview/Summary
Explore research on MOTS-c protein peptide and its role in mitochondrial signaling, metabolic regulation, and exercise response through scientific studies.
MOTS-c is a mitochondrial peptide that is composed of sixteen amino acids and is encoded by the mitochondrial genome. This "power generator" in the cell is the mitochondria, which are responsible for converting the chemical energy that is obtained from food into a form the cell can use.
Humanin and SHLP1-6 are two more mitochondria-derived peptides (MDPs) that have been found up to this point; however, it is not known whether or not they have a role in human physical performance.
Bioactive peptides that are produced from mitochondria, such as MOTS-c, have been shown to play a role in the maintenance of mitochondrial function and the protection of cells from various stresses, according to the most recent research [1].
It has been demonstrated that physical activity leads to an increase in mitochondrial-encoded MOTS-c levels in human beings [8]. Studies in mouse models have examined MOTS-c in relation to mitochondrial metabolism and nuclear gene expression [3].
Mechanism of Action of MOTS-c Peptide
The role of MOTS-c as a regulator of energy homeostasis aligns with current interest in peptides for metabolism, particularly those influencing amino acid, carbohydrate, and lipid pathways. In mammalian cells, it is encoded by mitochondrial DNA and, under stress conditions, translocates to the nucleus, accompanied by increased ROS generation. The nuclear translocation of MOTS-c is dependent on 5′-adenosine monophosphate-activated protein kinase (AMPK). MOTS-c also induces the activation of AMPK and the buildup of 5-aminomidazole-4-carboxamide ribonucleotide (AICAR), a recognized AMPK activator, by blocking the folate cycle and de novo purine production.
AMPK serves as the primary sensor and essential regulator of cellular metabolism in relation to energy availability. When the ATP:ADP or ATP:AMP ratios increase, AMPK is activated, leading to a shift in metabolism that promotes catabolism and inhibits anabolism through the phosphorylation of essential proteins in many pathways, including mTOR complex 1 (mTORC1).
Furthermore, under stress conditions, AMPK directly phosphorylates Peroxisome proliferator-activated receptor Gamma Co-activator-1α (PGC-1α) to activate it. PGC-1α governs the expression of mitochondrial antioxidants and is a crucial element in mito-nuclear communication. It may engage with Nuclear Factor, Erythroid -1 and -2 (NRF-1/2) to inhibit mitochondrial oxidative stress, facilitate the removal of impaired mitochondria, and augment mitochondrial biogenesis.
The protective effect of MOTS-c modulates several genes within the nucleus in response to metabolic dysfunction, including those with antioxidant response elements (ARE). It engages with ARE-regulating stress-responsive transcription factors, including Nuclear Factor Erythroid 2-Related Factor 2 (NFE2L2/NRF2).
NFE2L2/NRF2 is a transcription factor that responds to reactive oxygen species (ROS) and safeguards cells during oxidative stress. The activation of the NRF2/ARE pathway serves as an antioxidative effect in studies of acute kidney damage and vascular dysfunction. NRF2 notably interacts with AMPK and can modulate MOTS-c-associated metabolic pathways.
The MOTS-c/NRF2 interaction enhances mitochondrial protective genes, and the overexpression of MOTS-c amplifies NRF2 signaling. [3]
Research Evidence
Aging and MOTS-c
MOTS-C is an exercise-induced mitochondrial-encoded peptide whose metabolic level which is gradually disordered, is one of the indications of aging. This level of disorder inhibits the normal physiological function of the body and even causes individuals to lose the ability to take care of themselves independently.
In point of fact, one of the most important risk factors for chronic diseases is becoming older. In order for an organism to maintain its health, it is essential for its cellular responses to be able to adapt to the ever-changing internal and external settings.
In addition to producing a significant quantity of cellular energy, mitochondria are strongly associated with the process of aging, with exercise-induced mitochondrial-encoded regulator of age-dependent physical decline; however, the mechanism that underlies this phenomena suggest that MOTS-C expression is not fully understood. [1, 8]
MOTS-c and Cardiovascular Disease
One of the most significant contributors to cardiovascular issues is obesity.
In addition, obesity would result in the remodeling and dysfunction of the ventricles, which would ultimately lead to the destruction of the structure and physiological function of the heart, which would eventually result in heart failure.
An increasing body of research has demonstrated that there is a tight connection between MDP and the factors mentioned above. Furthermore, MDP has been examined for its effect on the pathological response of cardiovascular disease (CVD) through a variety of different mechanisms. [5]
MOTS-c and Insulin-Resistance
The development of insulin resistance can result in a reduction in the number of mitochondria in tissue cells as well as an irregular morphology of these mitochondria, which in turn makes it more difficult to produce ATP. According to its description, MOTS-c, a mitochondrial-derived peptide, is a "motion simulator" that regulates glucose metabolism in the body in a systematic manner and has been studied in insulin-signalling models. [6, 7]
Research Applications
It has been claimed that MOTS-c, which is a tiny molecular active peptide, may have potential applications in the investigation of age-related cellular mechanisms, insulin resistance, cardiovascular disease, and inflammation. Synthetic biology technologies have been proposed as a way to incorporate plasma MOTS-c into probiotics in order to achieve its accurate and controllable expression. [4]
However, the clinical trial and use of engineered bacteria are severely constrained by the virulence of bacteria as well as their immune response, which cannot be completely controlled. It is of the utmost importance for researchers to better characterize the properties of these microorganisms. In the present day, the approaches that are utilized the most frequently are surface-modified bacteria and gene-modified bacteria. Additionally, it has been demonstrated that certain naturally occurring bacteria, such as Lactobacillus (LAB) and Escherichia coli Nissle1917 (EcN), are safe for clinical use. The utilization of these bacteria as chassis bacteria is an area of ongoing research. [2, 3]
All findings referenced are from preclinical or early-stage research. MOTS-c is not approved for human research use.
Future Research Perspectives
Understanding specific molecular features of endogenous MOTS-c is an ongoing work. To ascertain how MOTS-c exerts its mechanism of action in preclinical models, further research into the mechanism of cell entry will be crucial. MOTS-c is being examined as a possible research target in a number of disease models. Synthetic biology techniques, such as gene editing and genetic engineering, are being explored to modify biological activity and deliver MOTS-c directly to the action site, thus further broadening the research application of MOTS-c. The subsequent biosafety issue, however, has consistently drawn attention. The reduction or elimination of genetically modified bacteria's toxicity to the body is a critical scientific issue that requires immediate attention.
References
Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol (2017) 595:6613–21.
Lee C, Yen K, Cohen P. Humanin: a harbinger of mitochondrial-derived peptides? Trends Endocrinol Metab (2013) 24:222–8.
Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab (2018) 28:516–524e7.
Popov LD. Mitochondrial peptides-appropriate options for therapeutic exploitation. Cell Tissue Res (2019) 377:161–5.
Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab (2015) 21:443–54.
Yin X, Jing Y, Chen Q, Abbas AB, Hu J, Xu H. The intraperitoneal administration of MOTS-c produces antinociceptive and anti-inflammatory effects through the activation of AMPK pathway in the mouse formalin test. Eur J Pharmacol (2020) 870:172909. doi: 10.1016/j.ejphar.2020.172909
Yang B, Yu Q, Chang B, Guo Q, Xu S, Yi X, et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1alpha expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim Biophys Acta Mol Basis Dis (2021) 1867:166126. doi: 10.1016/j.bbadis.2021.166126
Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun (2021) 12:470. doi: 10.1038/s41467-020-20790-0
Read more about peptides
GLP-3RT: Triple Receptor Agonist Research
GLP-3RT is a single peptide that activates the glucagon, GIP and GLP-1 receptors. A summary of its mechanism and the published in vitro and rodent research on triple receptor agonism.
ARA 290 Peptide: From Erythropoietin to Neuropathy Research
ARA 290, a nonhematopoietic peptide from erythropoietin's structure, activates the innate repair receptor and has been studied in models of tissue injury and neuropathic symptoms.